Article by: Raza Lawrence and Ivy Perez-Bader After more than fifty years of classification alongside heroin and LSD, cannabis may soon occupy the same legal category as ketamine and Tylenol with codeine. Following an Executive Order issued by President Trump in December 2025 directing the Attorney General to complete the rescheduling rulemaking process in an expeditious…
Article by: Tom Zuber and Radhi Shah Federal cannabis policy is entering an exciting phase, but businesses should be cautious about assuming clarity where none yet exists. The proposed move of marijuana from Schedule I to Schedule III under the Controlled Substances Act represents a meaningful policy shift, but it does not create a comprehensive federal cannabis framework.…
Unlicensed cannabis retailers take away tax revenue from state and local governments, and force those governments to divert needed public funding for investigation or prosecution. Unlicensed cannabis puts financial pressure on legal operators that are struggling to apply, comply, and prosper. Lack of quality control at unlicensed cannabis businesses also poses a public health risk…